|4Feb 26, 7:22 PM ET

El-Hibri Fuad 4

4 · Emergent BioSolutions Inc. · Filed Feb 26, 2021

Insider Transaction Report

Form 4
Period: 2021-02-24
El-Hibri Fuad
DirectorCEO & Chairman10% Owner
Transactions
  • Award

    Restricted Stock Unit

    2021-02-24+13,90613,906 total
    Common Stock (13,906 underlying)
  • Award

    Employee Stock Options (Right to Buy)

    2021-02-24+27,80827,808 total
    Exercise: $93.49Exp: 2031-02-23Common Stock (27,808 underlying)
Footnotes (3)
  • [F1]Restricted stock units convert into common stock on a one-for-one basis.
  • [F2]On February 24, 2021, Mr. El-Hibri was granted 27,808 stock options vesting in three approximately equal annual installments beginning on the day prior to the first anniversary of the grant date.
  • [F3]On February 24, 2021, Mr. El-Hibri was granted 13,906 restricted stock units vesting in three approximately equal annual installments beginning on the day prior to the first anniversary of the grant date.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION